DOLAFLEXIN

What this means for you

Registered since 21 Mar 2017. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

85943361

Registration number

5166648

Mark type

Stylized text

Filed

28 May 2013

Published for opposition

24 Dec 2013

Registered

21 Mar 2017

Attorney of record

Emilia F. Cannella

Goods and services

• Class 001 — Chemicals: Biodegradable polymer drug conjugates for use in the manufacture of pharmaceuticals and drug delivery systems; biodegradable polymer drug conjugates for use in bioconjugation with biomolecules; biodegradable polymer drug conjugates for use in the manufacture of pharmaceutical preparations, namely, drug delivery systems
• Class 005 — Pharmaceuticals: Biodegradable polymer drug conjugates sold as an integral component of pharmaceutical preparations, namely, drug delivery systems consisting of a biodegradable polymer and compounds that facilitate the delivery of a wide range of pharmaceuticals

Owner

• Mersana Therapeutics, Inc., Cambridge, MA, US
• Mersana Therapeutics, Inc., Cambridge, MA, US
• Mersana Therapeutics, Inc., Cambridge, MA, US

Prosecution history

• 21 Mar 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
• 02 Sept 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
• 02 Sept 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
• 02 Sept 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 06 Mar 2023 — TEAS SECTION 8 & 15 RECEIVED
• 21 Mar 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
• 21 Mar 2017 — REGISTERED-PRINCIPAL REGISTER
• 14 Feb 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 13 Feb 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 12 Feb 2017 — STATEMENT OF USE PROCESSING COMPLETE
• 03 Feb 2017 — USE AMENDMENT FILED
• 03 Feb 2017 — TEAS STATEMENT OF USE RECEIVED
• 13 Aug 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 12 Aug 2016 — SOU EXTENSION 5 GRANTED
• 21 Jul 2016 — SOU EXTENSION 5 FILED